"Foundation Medicine...announced plans to launch two new germline tests, FoundationOne Germline and FoundationOne Germline More, in the United States to identify genetic variants associated with hereditary cancers and can be used by healthcare providers to understand underlying risks for patients and their families. These tests will be offered through a partnership with Fulgent Genetics....The companies are planning for healthcare providers to be able to add FoundationOne Germline or FoundationOne Germline More to any Foundation Medicine comprehensive genomic profiling test, through Foundation Medicine's portal beginning February 28, 2025."
2 months ago
Licensing / partnership
|
FoundationOne® Germline • FoundationOne® Germline More